Press Release Samsung Begins Industry’s First Mass Production of QLC 9th-Gen V-NAND for AI Era 11 September 2024
Press Release AA Mission Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 16, 2024 11 September 2024
Press Release Civeo Corporation Announces Renewal of Share Repurchase Authorization 11 September 2024
Press Release Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair 11 September 2024
Press Release Anthem BCBS Foundation Distributes $300,000 to Three Food Banks in VA to Expand ‘Food as Medicine’ Initiatives Across the State 11 September 2024
Press Release AM Best Withdraws Credit Ratings of Consolidated National Insurance Company 11 September 2024
Press Release Net Asset Value Restatement for Simplify Aggregate Bond ETF (AGGH) & Simplify Volatility Premium ETF (SVOL) 11 September 2024
Press Release Novel computational pathology-based TROP2 biomarker for datopotamab deruxtecan was predictive of clinical outcomes in patients with non-small cell lung cancer in TROPION-Lung01 Phase III trial 8 September 2024
